{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T15:20:18Z","timestamp":1725636018795},"publisher-location":"Berlin, Heidelberg","reference-count":24,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783540509844"},{"type":"electronic","value":"9783642746437"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1990]]},"DOI":"10.1007\/978-3-642-74643-7_95","type":"book-chapter","created":{"date-parts":[[2011,11,21]],"date-time":"2011-11-21T01:03:37Z","timestamp":1321837417000},"page":"531-538","source":"Crossref","is-referenced-by-count":1,"title":["The Febrile Neutropenic Patient: Newer Options for Empirical Therapy"],"prefix":"10.1007","author":[{"given":"M.","family":"Rubin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lecciones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Roilides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gress","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. A.","family":"Pizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"95_CR1","doi-asserted-by":"publisher","first-page":"S734","DOI":"10.1093\/clinids\/7.Supplement_4.S734","volume":"4","author":"SC Schimpff","year":"1985","unstructured":"Schimpff SC (1985) Overview of empiric antibiotic therapy for the febrile neutropenic patient. Rev Infect Dis 7 Suppl 4: S734","journal-title":"Rev Infect Dis 7 Suppl"},{"key":"95_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3109\/07357908809077045","volume":"6","author":"M Rubin","year":"1988","unstructured":"Rubin M, Hathorn JW, Pizzo PA (1988) Controversies in the management of febrile neutropenic cancer patients. Cancer Investigation 6: 167","journal-title":"Cancer Investigation"},{"key":"95_CR3","first-page":"524","volume-title":"Antimicrobial agents annual","author":"M Rubin","year":"1988","unstructured":"Rubin M, Pizzo PA (1988) Monotherapy in neutropenic cancer patients. In: Peterson PK, Verhoef J (eds) Antimicrobial agents annual Elseviere Science, New York, p 524"},{"key":"95_CR4","first-page":"351","volume":"3","author":"SL Barriere","year":"1984","unstructured":"Barriere SL, Flaherty JF (1984) Third-generation cephalosporins: a critical evaluation. Clin Pharm 3: 351","journal-title":"Clin Pharm"},{"key":"95_CR5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.7326\/0003-4819-97-3-408","volume":"97","author":"HC Neu","year":"1982","unstructured":"Neu HC (1982) The new beta-lactamase-stable cephalosporins. Ann Intern Med 97: 408","journal-title":"Ann Intern Med"},{"key":"95_CR6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJM198608283150905","volume":"315","author":"PA Pizzo","year":"1986","unstructured":"Pizzo PA, Hathorn JW, Hiemenz JW et al. (1986) A randomized trial comparing combination antibiotic therapy to monotherapy in cancer patients with fever and neutropenia. N Engl J Med 315: 552","journal-title":"N Engl J Med"},{"key":"95_CR7","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJM198608283150910","volume":"315","author":"LS Young","year":"1986","unstructured":"Young LS (1986) Empirical antimicrobial therapy in the neutropenic host (editorial). N Engl J Med 315: 580","journal-title":"N Engl J Med"},{"key":"95_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0002-9343(86)90257-3","volume":"81","author":"JE Karp","year":"1986","unstructured":"Karp JE, Dick JD, Angelopulos C, Charache P, Green L, Burke P, Sarai R (1986) Empiric use of vancomycin during prolonged treatment-induced granulocytopenia: randomized, double-blind, placebo-controlled trial in patients with acute leukemia. Am J Med 81: 237","journal-title":"Am J Med"},{"key":"95_CR9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1128\/AAC.30.1.64","volume":"30","author":"BJ Kramer","year":"1986","unstructured":"Kramer BJ, Ramphal R, Rand K (1986) Randomized comparison between two ceftazidime-containing regimens and cephalothingentamicin-carbenicillin in febrile granulocytopenic cancer patients. Antimicrob Agents Chemother 30: 64","journal-title":"Antimicrob Agents Chemother"},{"key":"95_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/jac\/12.4.357","volume":"12","author":"PJ Darbyshire","year":"1983","unstructured":"Darbyshire PJ, Williamson DJ, Pedler SJ et al. (1983) Ceftazidime in the treatment of febrile immunosuppressed children. J Antimicrob Chemother 12 Suppl A: 357","journal-title":"J Antimicrob Chemother"},{"key":"95_CR11","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1093\/jac\/12.2.101","volume":"12","author":"V Fainstein","year":"1983","unstructured":"Fainstein V, Bodey GP, Elting L, Bolivar R, Keating MJ, McCredie KB, Valdivieso M (1983) A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients. J Antimicrob Chemother 12 Suppl A: S101","journal-title":"J Antimicrob Chemother"},{"key":"95_CR12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jac\/12.suppl_A.81","volume":"12","author":"R Ramphal","year":"1983","unstructured":"Ramphal R, Kramer BS, Rand KH, Weiner RS, Shands JW (1983) Early results of a comparative trial of ceftazidime versus cephalothin, carbenicillin, and gentamicin in the treatment of febrile granulocytopenic patients. J Antimicrob Chemother 12 Suppl A: 81","journal-title":"J Antimicrob Chemother"},{"key":"95_CR13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/jac\/12.4.347","volume":"12","author":"G Morgan","year":"1983","unstructured":"Morgan G, Duerden BI, Lilleyman JS (1983) Ceftazidime as a single agent in the management of children with fever and neutropenia. J Antimicrob Chemother 12 Suppl A: 347","journal-title":"J Antimicrob Chemother"},{"key":"95_CR14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7326\/0003-4819-108-1-30","volume":"108","author":"M Rubin","year":"1988","unstructured":"Rubin M, Hathorn JW, Marshall D, Gress J, Steinberg SM, Pizzo PA (1988) Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Ann Intern Med 108: 30","journal-title":"Ann Intern Med"},{"key":"95_CR15","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1056\/NEJM198810203191604","volume":"319","author":"JL Shenep","year":"1988","unstructured":"Shenep JL, Hughes WT, Roberson PK et al. (1988) Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile neutropenic children with cancer. N Engl J Med 319: 1053","journal-title":"N Engl J Med"},{"key":"95_CR16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1128\/AAC.30.2.211","volume":"30","author":"GP Bodey","year":"1986","unstructured":"Bodey GP, Alvarez ME, Jones PG, Rolston KVI, Steelhammer L, Fainstein V (1986) Antimicrob Agents Chemother 30: 211","journal-title":"Antimicrob Agents Chemother"},{"key":"95_CR17","first-page":"315","volume":"1251","author":"J Wade","year":"1987","unstructured":"Wade J, Bustamante C, Devlin A et al. (1987) Imipenem vs piperacillin plus amikacin, empiric therapy for febrile neutropenic patients: a double blind trial. Program and Abstracts, 27th Interscience Conference on Antimicrobial Agents Chemother 1251: 315","journal-title":"Program and Abstracts, 27th Interscience Conference on Antimicrobial Agents Chemother"},{"key":"95_CR18","first-page":"315","volume":"1254","author":"J Falloon","year":"1987","unstructured":"Falloon J, Rubin M, Hathorn J et al. (1987) Is a carbapenem as effective as a 3rd generation cephalosporin when used as monotherapy in the empiric treatment of the febrile neutropenic patient? Program and Abstracts, 27th Interscience Conference on Antimicrobial Agents Chemother 1254: 315","journal-title":"Program and Abstracts, 27th Interscience Conference on Antimicrobial Agents Chemother"},{"key":"95_CR19","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/0002-9343(86)90633-9","volume":"80","author":"DJ Winston","year":"1986","unstructured":"Winston DJ, Ho WG, Nakao SL, Gale RP, Champlin RE (1986) Norfloxacin versus Vancomycin\/ polymyxin for prevention of infections in granulocytopenic patients. Am J Med 80: 884","journal-title":"Am J Med"},{"key":"95_CR20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-106-1-7","volume":"106","author":"AW Dekker","year":"1987","unstructured":"Dekker AW, Rozenberg-Arska M, Verhoef J (1987) Infection prophylaxis in acute leukemia; a comparison of ciprofloxacin with trimethroprim-sulfamethoxazole and colistin. Ann Intern Med 106: 7","journal-title":"Ann Intern Med"},{"key":"95_CR21","first-page":"66","volume":"48","author":"JE Karp","year":"1986","unstructured":"Karp JE, Merz WG, Hendrickson C et al. (1986) Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tract. Scand J Infect Dis (Suppl) 48: 66","journal-title":"Scand J Infect Dis (Suppl)"},{"key":"95_CR22","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/0002-9343(88)90062-9","volume":"84","author":"EJ Bow","year":"1988","unstructured":"Bow EJ, Rayner E, Louie TJ (1988) Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis. Am J Med 84: 847","journal-title":"Am J Med"},{"key":"95_CR23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0002-9343(86)90258-5","volume":"81","author":"PG Jones","year":"1986","unstructured":"Jones PG, Rolston KV, Fainstein V, Elting L, Walters R, Bodey GP (1986) Aztreonam therapy in neutropenic patients with cancer. Am J Med 81: 243","journal-title":"Am J Med"},{"issue":"2","key":"95_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0002-9343(85)90198-6","volume":"78","author":"A Saxon","year":"1985","unstructured":"Saxon A, Swabb E, Adkinson NF (1985) Investigation into the immunologic cross-reactivity of aztreonam with other beta-lactam antibiotics. Am J Med 78 (Suppl 2 A): 19","journal-title":"Am J Med"}],"container-title":["Haematology and Blood Transfusion \/ H\u00e4matologie und Bluttransfusion","Acute Leukemias II"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-74643-7_95.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T21:29:26Z","timestamp":1606253366000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-74643-7_95"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990]]},"ISBN":["9783540509844","9783642746437"],"references-count":24,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-74643-7_95","relation":{},"ISSN":["0440-0607"],"issn-type":[{"type":"print","value":"0440-0607"}],"subject":[],"published":{"date-parts":[[1990]]}}}